Free Trial

Federated Hermes (FHI) 10K Form and Latest SEC Filings 2026

Federated Hermes logo
$55.10 +1.10 (+2.04%)
Closing price 03:59 PM Eastern
Extended Trading
$55.52 +0.43 (+0.77%)
As of 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Federated Hermes SEC Filings & Recent Activity

Federated Hermes (NYSE:FHI) has submitted 570+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Federated Hermes's financial statements. The most recent filing was a Form S-8 submitted on May 4, 2026.

Form 4
FEDERATED HERMES, INC. Reports Ownership Change on May. 4, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Federated Hermes Files Current Report on Apr. 30, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Federated Hermes Files Quarterly Report on May. 1, 2026

The 10-Q contains Federated Hermes's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Federated Hermes SEC Filing History

Browse Federated Hermes' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/04/2026 3:30 PM
Federated Hermes (1056288) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/04/2026 3:05 PM
BARTOLACCI JOSEPH C (1211955) Reporting
Federated Hermes (1056288) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2026 3:05 PM
Burke Bryan M (2124754) Reporting
Federated Hermes (1056288) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2026 3:05 PM
Federated Hermes (1056288) Issuer
Uhlman Paul A (1676267) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2026 3:05 PM
Federated Hermes (1056288) Issuer
Hanlon Karen (2013588) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2026 3:05 PM
Federated Hermes (1056288) Issuer
Jones Marie Milie (1606377) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2026 3:21 PM
Federated Hermes (1056288) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2026 3:06 PM
Burke Bryan M (2124754) Reporting
Federated Hermes (1056288) Issuer
Form 3
Initial statement of beneficial ownership of securities  
04/30/2026 4:17 PM
Federated Hermes (1056288) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2026 11:45 AM
Federated Hermes (1056288) Subject
VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by
Form SCHEDULE 13G
04/09/2026 3:29 PM
Federated Hermes (1056288) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2026 6:49 AM
Federated Hermes (1056288) Filed by
Smith Douglas Homes Corp. (1982518) Subject
Form SCHEDULE 13G/A
04/07/2026 6:50 AM
Federated Hermes (1056288) Filed by
SOUNDTHINKING, INC. (1351636) Subject
Form SCHEDULE 13G/A
04/07/2026 6:22 AM
ADVANCE AUTO PARTS INC (1158449) Subject
Federated Hermes (1056288) Filed by
Form SCHEDULE 13G
04/07/2026 6:24 AM
Federated Hermes (1056288) Filed by
MGP INGREDIENTS INC (835011) Subject
Form SCHEDULE 13G/A
03/26/2026 5:22 PM
Federated Hermes (1056288) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/16/2026 3:32 PM
Federated Hermes (1056288) Issuer
Uhlman Paul A (1676267) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2026 3:33 PM
DONAHUE THOMAS R (1061438) Reporting
Federated Hermes (1056288) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 3:11 PM
Federated Hermes (1056288) Subject
Novak Richard A (1352542) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2026 3:12 PM
Federated Hermes (1056288) Subject
Nusseibeh Saker Anwar (1744486) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2026 3:12 PM
Federated Hermes (1056288) Subject
Uhlman Paul A (1676267) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2026 3:14 PM
Federated Hermes (1056288) Subject
Van Meter Stephen (1648530) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2026 3:19 PM
Federated Hermes (1056288) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2026 1:00 PM
Federated Hermes (1056288) Filer
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/02/2026 3:08 PM
Federated Hermes (1056288) Subject
Nusseibeh Saker Anwar (1744486) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2026 3:26 PM
Federated Hermes (1056288) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2026 4:10 PM
Federated Hermes (1056288) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2026 10:56 AM
Federated Hermes (1056288) Filed by
Ovid Therapeutics Inc. (1636651) Subject
Form SCHEDULE 13G
01/08/2026 11:06 AM
Federated Hermes (1056288) Filed by
TTEC Holdings, Inc. (1013880) Subject
Form SCHEDULE 13G
01/08/2026 7:15 AM
Federated Hermes (1056288) Filed by
IDEAYA Biosciences, Inc. (1676725) Subject
Form SCHEDULE 13G/A
01/08/2026 7:17 AM
Federated Hermes (1056288) Filed by
MGP INGREDIENTS INC (835011) Subject
Form SCHEDULE 13G/A
01/08/2026 7:19 AM
Federated Hermes (1056288) Filed by
SCYNEXIS INC (1178253) Subject
Form SCHEDULE 13G/A
01/08/2026 7:12 AM
Arcturus Therapeutics Holdings Inc. (1768224) Subject
Federated Hermes (1056288) Filed by
Form SCHEDULE 13G/A
12/29/2025 7:29 AM
Federated Hermes (1056288) Filed by
Minerva Neurosciences, Inc. (1598646) Subject
Form SCHEDULE 13G
12/12/2025 3:27 PM
Dudiak Dolores D (1845664) Reporting
Federated Hermes (1056288) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2025 3:22 PM
Federated Hermes (1056288) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2025 3:07 PM
Federated Hermes (1056288) Issuer
Germain Peter J (1482366) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:07 PM
Federated Hermes (1056288) Issuer
Novak Richard A (1352542) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:08 PM
Dudiak Dolores D (1845664) Reporting
Federated Hermes (1056288) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:08 PM
Federated Hermes (1056288) Issuer
Nusseibeh Saker Anwar (1744486) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:01 PM
DONAHUE THOMAS R (1061438) Reporting
Federated Hermes (1056288) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:01 PM
DONAHUE J CHRISTOPHER (918972) Reporting
Federated Hermes (1056288) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:01 PM
Federated Hermes (1056288) Issuer
Zierden Theodore W III (2031165) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:01 PM
Federated Hermes (1056288) Issuer
Uhlman Paul A (1676267) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:02 PM
Federated Hermes (1056288) Issuer
Van Meter Stephen (1648530) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2025 3:06 PM
Federated Hermes (1056288) Issuer
FISHER JOHN B (1061439) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2025 3:24 PM
Dudiak Dolores D (1845664) Reporting
Federated Hermes (1056288) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2025 3:27 PM
Federated Hermes (1056288) Subject
Germain Peter J (1482366) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2025 3:09 PM
Federated Hermes (1056288) Subject
Uhlman Paul A (1676267) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2025 3:09 PM
Federated Hermes (1056288) Subject
Zierden Theodore W III (2031165) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2025 3:11 PM
Federated Hermes (1056288) Subject
FISHER JOHN B (1061439) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2025 3:13 PM
Federated Hermes (1056288) Subject
Novak Richard A (1352542) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2025 3:21 PM
Federated Hermes (1056288) Subject
Van Meter Stephen (1648530) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2025 4:14 PM
Federated Hermes (1056288) Issuer
Germain Peter J (1482366) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2025 9:19 AM
Federated Hermes (1056288) Subject
Germain Peter J (1482366) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2025 9:28 AM
Federated Hermes (1056288) Filed by
MGP INGREDIENTS INC (835011) Subject
Form SCHEDULE 13G
11/03/2025 4:13 PM
Federated Hermes (1056288) Issuer
Nusseibeh Saker Anwar (1744486) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2025 9:48 AM
Federated Hermes (1056288) Filer
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
10/31/2025 3:19 PM
Federated Hermes (1056288) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2025 4:27 PM
Federated Hermes (1056288) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2025 3:39 PM
Federated Hermes (1056288) Filed by
Minerva Neurosciences, Inc. (1598646) Subject
Form SCHEDULE 13D
10/23/2025 4:00 PM
Federated Hermes (1056288) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2025 10:14 AM
Federated Hermes (1056288) Filed by
SOUNDTHINKING, INC. (1351636) Subject
Form SCHEDULE 13G/A
10/07/2025 10:03 AM
aTYR PHARMA INC (1339970) Subject
Federated Hermes (1056288) Filed by
Form SCHEDULE 13G/A
10/07/2025 10:08 AM
Federated Hermes (1056288) Filed by
Forte Biosciences, Inc. (1419041) Subject
Forte Biosciences, Inc. (1419041) Subject
Form SCHEDULE 13G/A
10/07/2025 10:11 AM
Federated Hermes (1056288) Filed by
SCYNEXIS INC (1178253) Subject
Form SCHEDULE 13G/A
08/28/2025 3:39 PM
DONAHUE THOMAS R (1061438) Reporting
Federated Hermes (1056288) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2025 9:36 AM
Federated Hermes (1056288) Filer
Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company  
08/13/2025 1:50 PM
Federated Hermes (1056288) Filer
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
07/31/2025 4:14 PM
Federated Hermes (1056288) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025 6:50 AM
Federated Hermes (1056288) Filed by
Forte Biosciences, Inc. (1419041) Subject
Forte Biosciences, Inc. (1419041) Subject
Form SCHEDULE 13G
07/08/2025 6:30 AM
EyePoint Pharmaceuticals, Inc. (1314102) Subject
Federated Hermes (1056288) Filed by
Form SCHEDULE 13G/A
06/16/2025 3:33 PM
Federated Hermes (1056288) Subject
Uhlman Paul A (1676267) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2025 8:19 AM
Federated Hermes (1056288) Filed by
Virgin Galactic Holdings, Inc (1706946) Subject
Form SCHEDULE 13G/A
05/27/2025 3:17 PM
Federated Hermes (1056288) Subject
Uhlman Paul A (1676267) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2025 3:23 PM
Federated Hermes (1056288) Subject
Germain Peter J (1482366) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2025 6:19 AM
Federated Hermes (1056288) Filer
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
(Data available from 1/1/2016 forward)

Federated Hermes SEC Filings - Frequently Asked Questions

Federated Hermes (FHI) has submitted 570+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Federated Hermes's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Federated Hermes's financial statements page.

The most recent filing was a Form S-8 submitted on May 4, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:FHI) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners